Unclassified acute myeloid leukemia Advocacy Hub | UniteRare

At a Glance

Live from database

💊

2FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Unclassified acute myeloid leukemia.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Mylotarg

Wyeth Pharmaceuticals, Inc., a Pfizer Company

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Mylotarg

(Gemtuzumab ozogamicin)Orphan drugstandard

Wyeth Pharmaceuticals, Inc., a Pfizer Company

CD33-directed Immunoconjugate [EPC]

12.1 Mechanism of Action Gemtuzumab ozogamicin is a CD33-directed antibody-drug conjugate (ADC). The antibody portion (hP67.6) recognizes human CD33 a...

FDA label ↗

Tibsovo

(IVOSIDENIB)Orphan drugstandard

Servier Pharmaceutical LLC

Isocitrate Dehydrogenase 1 Inhibitor [EPC]

12.1 Mechanism of Action Ivosidenib is a small molecule inhibitor that targets the mutant isocitrate dehydrogenase 1 (IDH1) enzyme. In patients with A...

FDA label ↗

View full treatment details on disease page →